Is amiodarone an inducer or inhibitor of cytochrome P450 enzymes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amiodarone is a Potent Inhibitor of Cytochrome P450 Enzymes

Amiodarone functions as a potent inhibitor—not an inducer—of multiple cytochrome P450 enzymes, specifically CYP2C9, CYP2D6, and CYP3A4, as well as P-glycoprotein. 1

Mechanism of Inhibition

Amiodarone blocks the metabolism of other drugs through several CYP pathways 2:

  • CYP2C9: Metabolizes warfarin
  • CYP2D6: Metabolizes beta blockers and narcotics
  • CYP3A4: Metabolizes cyclosporine and calcium channel blockers
  • P-glycoprotein: Affects digoxin secretion from renal tubules

The FDA label explicitly states that "Amiodarone is an inhibitor of CYP3A4 and p-glycoprotein" and that "Amiodarone inhibits p-glycoprotein and certain CYP450 enzymes, including CYP1A2, CYP2C9, CYP2D6, and CYP3A4." 1

Clinical Significance: The Metabolite Matters More

Desethylamiodarone (amiodarone's primary metabolite) is actually a more potent inhibitor than the parent drug itself. Research demonstrates that desethylamiodarone has higher 1+Iu/Ki values than amiodarone, meaning drug interactions primarily occur via the metabolite rather than amiodarone alone 3. This metabolite competitively inhibits CYP2D6 with a Ki of 4.5 μM and noncompetitively inhibits CYP2A6, CYP2B6, and CYP3A4 3.

Critical Drug Interactions Requiring Dose Adjustments

Warfarin

  • Amiodarone reduces warfarin clearance through CYP2C9 inhibition
  • Peak interaction effects occur approximately 7 weeks after starting amiodarone
  • Monitor PT/INR at least weekly during the first 6 weeks 2

Digoxin

  • Digoxin levels predictably double when co-administered with amiodarone
  • Mechanism: Inhibition of P-glycoprotein-mediated renal tubular secretion
  • Reduce digoxin dose by 50% when starting amiodarone 2
  • Monitor digoxin levels closely

Other Antiarrhythmics

  • Quinidine serum concentration increases by 33% after 2 days
  • Procainamide and N-acetyl procainamide increase by 55% and 33% respectively
  • Reduce quinidine and procainamide doses by one-third 1

Statins

  • Simvastatin (CYP3A4 substrate) combined with amiodarone increases myopathy/rhabdomyolysis risk 1

Important Clinical Caveat

The inhibitory effects persist long after discontinuation due to amiodarone's extremely long half-life (up to 100 days). Drug interactions can occur with medications started weeks to months after stopping amiodarone 1.

Common Pitfall to Avoid

Do not confuse amiodarone with enzyme inducers. Grapefruit juice actually increases amiodarone levels by 50% (AUC) and 84% (Cmax), confirming its substrate status for CYP3A4 rather than inducer properties 1. Patients must avoid grapefruit juice during amiodarone therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.